Skip to content
Search

Latest Stories

3 children hospitalised after norovirus outbreak at Winchester primary school

A deep clean has been scheduled at the school

Norovirus Outbreak at Winchester School Leads to Hospitalizations

Norovirus, often referred to as the winter vomiting bug

iStock

An outbreak of norovirus at a primary school near Winchester has resulted in three children being admitted to hospital, local authorities have confirmed.

Seven pupils from a single class at Compton All Saints Church of England Primary School were affected by the highly contagious virus, which causes vomiting and diarrhoea. The outbreak prompted the children to stay home from school on Thursday, with three requiring hospital treatment.


Hampshire County Council confirmed the incident, stating that the school has taken precautionary measures following advice from Public Health. The 120-pupil school, which caters to children aged 4 to 11, said it had been advised to isolate the affected class from the rest of the school. However, as this was not feasible due to logistical constraints, the school opted to close the class on Friday.

A deep clean has been scheduled at the school, which was already due to close on Friday afternoon for the half-term break. Parents have been informed of the outbreak and provided with information about norovirus from Public Health England.

Norovirus, often referred to as the winter vomiting bug, is a common cause of gastroenteritis and is highly infectious. While it is most prevalent during the colder months, it can spread at any time of the year. Symptoms typically include the sudden onset of nausea, vomiting, and diarrhoea, and usually last around two days.

Public Health officials are continuing to monitor the situation at the Winchester-area school. The deep cleaning and class closure are intended to limit further transmission and ensure the premises are safe for pupils' return after the break.

More For You

Weight Loss Drug

Health officials expect the rollout to benefit around 220,000 adults over the next 3 years

iStock

NHS GPs to prescribe Mounjaro in nationwide obesity treatment plan

Key points

  • NHS GPs in England can now prescribe Mounjaro (tirzepatide) for weight loss
  • The programme aims to support 220,000 people over three years
  • Eligible patients must have a BMI over 40 and at least four obesity-related health issues
  • GP leaders raise concerns over increased workload
  • Pharmacists urge a broader weight management approach

NHS expands obesity treatment with Mounjaro

The NHS in England is set to begin prescribing Mounjaro, a weight loss injection, through GP surgeries starting Monday. The move marks the first time family doctors will be authorised to directly prescribe the anti-obesity drug tirzepatide as part of a wider national health initiative.

Health officials expect the rollout to benefit around 220,000 adults over the next three years. The drug will be made available to those with a body mass index (BMI) above 40 who also suffer from at least four other obesity-related conditions, such as type 2 diabetes, high blood pressure, or sleep apnoea.

Keep ReadingShow less
UK heatwave deaths

Around 85% of the projected deaths are likely to involve people over the age of 65

iStock

Scientists warn current UK heatwave may cause nearly 600 early deaths

Almost 600 premature deaths are expected to occur during the ongoing heatwave affecting England and Wales, according to a new rapid analysis by leading scientists. The majority of fatalities are projected among older adults, with London and the West Midlands likely to be the worst-affected areas.

Climate change driving deadly temperatures

Researchers say the extreme temperatures, which have reached 32°C in parts of south-east England, would have been nearly impossible without the influence of human-caused climate change. Pollution from burning fossil fuels has raised the likelihood of such heatwaves by around 100 times, experts say.

Keep ReadingShow less
Amycretin

'The Lancet' and presentations at the American Diabetes Association’s 2025

iStock

New weight-loss pill Amycretin shows greater impact than jabs, study finds

A new weight-loss drug, amycretin, has delivered the most significant results yet for appetite-suppressing GLP-1 medications, according to two newly published studies in The Lancet and presentations at the American Diabetes Association’s 2025 Scientific Sessions in Chicago.

Record weight loss from Amycretin injections

Researchers found that participants receiving high-dose weekly injections of amycretin lost 24.3 per cent of their body weight over 36 weeks. This outcome surpasses the results seen in longer trials involving other GLP-1 drugs such as tirzepatide (sold as Mounjaro), which previously led the field with an average weight loss of 20 per cent over 72 weeks.

Keep ReadingShow less
Hulk Hogan

Hogan’s current hospital stay follows a neck fusion surgery he underwent in May 2025

Getty Images

Hulk Hogan hospitalised for back and neck issues, rep confirms he is not on deathbed

WWE Hall of Famer Hulk Hogan has been hospitalised for ongoing neck and back issues, but representatives have confirmed he is not in critical condition, dismissing online speculation suggesting otherwise.

The 71-year-old wrestling icon, whose real name is Terry Bollea, was reported by TMZ Sports to be undergoing treatment related to injuries sustained during his decades-long in-ring career. His representative said Hogan is already mobile again and “not on his deathbed”, following false claims made on air by Florida radio personality Bubba the Love Sponge.

Keep ReadingShow less
UK heatwave health risks

Several hidden threats linked to heat waves often go unnoticed

iStock

7 hidden heatwave health risks you may overlook

As temperatures across the UK continue to rise, so too do the health risks associated with extreme heat. While sunburn and dehydration are well-known dangers, several hidden threats linked to heat waves often go unnoticed. With climate change intensifying the frequency and severity of hot spells, some forecasts suggesting 40 °C days could become a regular feature in the next 12 years, it’s essential to understand these lesser-known risks and how to protect yourself.

1. Skin reactions triggered by common medications

Certain widely-used medications can increase sensitivity to sunlight, making people more prone to rashes, blistering, and sunburn—even on cloudy days. This includes nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen, some antibiotics such as doxycycline, statins, antidepressants, and hormone replacement therapy (HRT).

Keep ReadingShow less